0.0837
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-567.6510
-173.9170
-606.9210
-1,130.9380
18.6450
Investing Cash Flow
--
--
25.0000
495.0000
--
Financing Cash Flow
628.8080
243.7500
-94.0360
1,363.1000
-26.5000
End Cash Position
61.8490
121.0370
51.2040
727.1620
--
Interest Paid Supplemental Data
--
--
27.4730
--
--
Issuance of Debt
--
243.7500
0.4990
1,363.1000
--
Repayment of Debt
--
--
-94.5350
--
-26.5000
Free Cash Flow
-567.6510
-173.9170
-606.9210
-1,130.9380
18.6450
9/30/2020 - 4/20/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MCET MultiCell Technologies, Inc.
0.0000
0.00%
GSTC GlobeStar Therapeutics Corporation
0.0003
0.00%
CSCI.TO COSCIENS Biopharma Inc.
3.8000
-5.00%
ENZN Enzon Pharmaceuticals, Inc.
0.1500
+2.74%
ADXS Ayala Pharmaceuticals, Inc.
0.0286
0.00%
AVIR Atea Pharmaceuticals, Inc.
3.0600
+2.34%
SNGX Soligenix, Inc.
2.3300
+0.87%
OGEN Oragenics, Inc.
0.3090
+0.78%
ENZC Enzolytics, Inc.
0.0009
0.00%
ERNA Eterna Therapeutics Inc.
0.3784
+3.28%